Tillar-Wenstrup Advisors, LLC - Q1 2014 holdings

$110 Million is the total value of Tillar-Wenstrup Advisors, LLC's 41 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 57.1% .

 Value Shares↓ Weighting
PRF SellFTSE RAFI US 1000$12,103,000
-9.6%
142,990
-11.4%
11.00%
-20.1%
VRX SellValeant Pharmaceuticals$3,455,000
+1.6%
26,211
-9.5%
3.14%
-10.3%
BAC SellBank of America$2,230,000
+6.0%
129,668
-4.0%
2.03%
-6.3%
VYM ExitVanguard High Dividend Yield ETF$0-40,210
-100.0%
-2.58%
V ExitVisa, Inc.$0-11,356
-100.0%
-2.60%
TMO ExitThermo Fisher Scientific$0-22,979
-100.0%
-2.63%
VOYA ExitING U.S., Inc.$0-81,290
-100.0%
-2.94%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-04-23
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Vanguard Mid-Cap ETF37Q4 20225.5%
Apple Inc.32Q4 20223.2%
iShares MSCI USA Min Vol31Q4 202215.4%
Vanguard FTSE All-World ex-US ETF30Q4 20224.2%
iShares MSCI USA Momentum27Q4 202210.7%
Vanguard Value26Q4 20226.4%
Berkshire Hathaway Cl B25Q4 20223.8%
Pepsico25Q4 20222.4%
Voya Financial Inc.24Q4 20193.7%
iShares MSCI International Quality22Q2 20220.4%

View Tillar-Wenstrup Advisors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR/A2024-02-14
13F-HR2024-02-08
13F-HR2023-11-13
13F-HR2023-08-15
13F-HR2023-05-04
13F-HR2023-01-24
13F-HR2022-10-25
13F-HR2022-07-22
13F-HR2022-04-22
13F-HR2022-01-28

View Tillar-Wenstrup Advisors, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (110000000.0 != 109985000.0)

Export Tillar-Wenstrup Advisors, LLC's holdings